$CHMX
NEXT-ChemX Corporation. Stock $chmx

$chmx Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224027787 Filed on July 15, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$482.1K	$436.7K
YoY Change		10.42%	16.72%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$1.330K	$1.330K
YoY Change		0.0%	10.83%
% of Gross Profit
Operating Expenses	$319.4K	$482.1K	$436.7K
YoY Change	-20.82%	10.42%	16.72%
Operating Profit	-$319.4K	-$482.1K	-$436.7K
YoY Change	-20.82%	10.42%	16.72%
Interest Expense		-$36.83K	$21.32K
YoY Change		-272.75%	-254.72%
% of Operating Profit
Other Income/Expense, Net	-$35.05K	-$36.83K	-$21.32K
YoY Change	-93.25%	72.73%	54.71%
Pretax Income		-$519.0K	-$458.0K
YoY Change		13.32%	18.07%
Income Tax
% Of Pretax Income
Net Earnings	-$354.5K	-$519.0K	-$458.0K
YoY Change	-61.59%	13.32%	18.07%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	-$0.02	-$0.02
Diluted Earnings Per Share	-$0.01	-$0.02	-$0.02
COMMON SHARES
Basic Shares Outstanding	28.55M shares	28.55M shares	28.85M shares
Diluted Shares Outstanding	28.55M shares	28.55M shares	28.37M shares

Balance Sheet

Concept	2024 Q3	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$139.7K	$142.2K
YoY Change		-1.74%	690.44%
Cash & Equivalents	$35.39K	$94.77K	$142.2K
Short-Term Investments		$44.96K
Other Short-Term Assets	$68.23K	$44.96K	$13.33K
YoY Change	-6.45%	237.26%	733.13%
Inventory
Prepaid Expenses			$1.600K
Receivables
Other Receivables
Total Short-Term Assets	$694.7K	$216.8K	$155.5K
YoY Change	195.18%	39.41%	693.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.619K	$11.29K	$16.62K
YoY Change	-38.24%	-32.1%	-18.27%
Goodwill
YoY Change
Intangibles	$3.150M	$3.150M	$3.150M
YoY Change	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.159M	$3.161M	$3.167M
YoY Change	-0.17%	-0.17%	-0.12%
TOTAL ASSETS
Total Short-Term Assets	$694.7K	$216.8K	$155.5K
Total Long-Term Assets	$3.159M	$3.161M	$3.167M
Total Assets	$3.853M	$3.378M	$3.322M
YoY Change	13.36%	1.68%	4.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$803.0K	$529.6K
YoY Change		51.63%	21.54%
Accrued Expenses		$1.829M	$1.150M
YoY Change		59.11%	86.0%
Deferred Revenue
YoY Change
Short-Term Debt		$1.017M	$857.2K
YoY Change		18.7%	590.61%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.482M	$4.162M	$2.548M
YoY Change	30.06%	63.3%	36.61%
LONG-TERM LIABILITIES
Long-Term Debt		$365.0K	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.220M	$365.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.482M	$4.162M	$2.548M
Total Long-Term Liabilities	$1.220M	$365.0K	$0.00
Total Liabilities	$5.702M	$4.527M	$2.548M
YoY Change	65.47%	77.63%	36.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.273M	-$6.573M	-$4.151M
YoY Change	32.94%	58.36%
Common Stock	$28.55K	$28.55K	$28.45K
YoY Change	0.0%	0.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.849M	-$1.148M	$773.9K
YoY Change
Total Liabilities & Shareholders Equity	$3.853M	$3.378M	$3.322M
YoY Change	13.36%	1.68%	4.15%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$354.5K	-$519.0K	-$458.0K
YoY Change	-61.59%	13.32%	18.07%
Depreciation, Depletion And Amortization		$1.330K	$1.330K
YoY Change		0.0%	10.83%
Cash From Operating Activities		-$292.7K	-$310.1K
YoY Change		-5.63%	180.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$385.0K	$424.0K
YoY Change		-9.2%	258.65%
NET CHANGE
Cash From Operating Activities		-$292.7K	-$310.1K
Cash From Investing Activities
Cash From Financing Activities		$385.0K	$424.0K
Net Change In Cash		$92.31K	$113.8K
YoY Change		-18.92%
FREE CASH FLOW
Cash From Operating Activities		-$292.7K	-$310.1K
Capital Expenditures
Free Cash Flow		-$292.7K	-$310.1K
YoY Change		-5.63%	180.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Notes Payable NotesPayable		usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q1	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2023Q1	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2023Q1	us-gaap	Debt Securities Trading Unrealized Loss DebtSecuritiesTradingUnrealizedLoss		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	CHMX	Common Stock Issued On Conversion Of3rd Party Loan CommonStockIssuedOnConversionOf3rdPartyLoan		usd
CY2023Q1	CHMX	Common Stock Issued On Conversion Of3rd Party Loan CommonStockIssuedOnConversionOf3rdPartyLoan		usd
CY2024Q1	CHMX	Common Stock Issued On Conversion Of Related Party Notes Payable And Accrued Interest CommonStockIssuedOnConversionOfRelatedPartyNotesPayableAndAccruedInterest		usd
CY2023Q1	CHMX	Common Stock Issued On Conversion Of Related Party Notes Payable And Accrued Interest CommonStockIssuedOnConversionOfRelatedPartyNotesPayableAndAccruedInterest		usd
CY2024Q1	CHMX	Stock Issued On3rd Party As Other Expense StockIssuedOn3rdPartyAsOtherExpense		usd
CY2023Q1	CHMX	Stock Issued On3rd Party As Other Expense StockIssuedOn3rdPartyAsOtherExpense		usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28546834	shares
CY2024Q1	us-gaap	Cash Cash	94770	usd
CY2023Q4	us-gaap	Cash Cash	2458	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	44957	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	64944	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77103	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	72925	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	216830	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	140327	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11287	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12621	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3150114	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3150114	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	3161401	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3162735	usd
CY2024Q1	us-gaap	Assets Assets	3378231	usd
CY2023Q4	us-gaap	Assets Assets	3303062	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2632132	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2443207	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	965000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	945000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4161557	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3932425	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	365000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	365000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4526557	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3932425	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28546834	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28546834	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28546834	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28546834	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	28547	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	28547	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5396053	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5396053	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6572926	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6053963	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1148326	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-629363	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3378231	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3303062	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	482136	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	436653	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	482136	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	436653	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-482136	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-436653	usd
CY2024Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	36827	usd
CY2023Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	21320	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36827	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21320	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-518963	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-457973	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28546834	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28546834	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28374612	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28374612	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-629363	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-518963	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1148326	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	731868	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	731868	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-457973	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	773895	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	773895	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-457973	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1334	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1334	usd
CY2024Q1	us-gaap	Debt Securities Trading Unrealized Loss DebtSecuritiesTradingUnrealizedLoss	19987	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	20207	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4178	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-8839	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	188925	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	137655	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-292688	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-310145	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	365000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75000	usd
CY2024Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	20000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	151007	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	385000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	423993	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	92312	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	113848	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2458	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28355	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94770	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	142203	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6572926	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-518963	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-457973	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-292688	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-310145	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	513800	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	1895127	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zRq2F2GgObAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zMo9gYbIbYdi">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could and likely will differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3150114	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77103	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	72925	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4178	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3150114	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	803012	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	698009	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1715842	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1668748	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	113278	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	76450	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2632132	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2443207	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	1330000	usd
CY2024Q1	CHMX	Long Term Debt Maturities Repayments Of Principal In Second Quarter LongTermDebtMaturitiesRepaymentsOfPrincipalInSecondQuarter	120000	usd
CY2024Q1	CHMX	Long Term Debt Maturities Repayments Of Principal In Thrid Quarter LongTermDebtMaturitiesRepaymentsOfPrincipalInThridQuarter	250000	usd
CY2024Q1	CHMX	Long Term Debt Maturities Repayments Of Principal In Fourth Quarter LongTermDebtMaturitiesRepaymentsOfPrincipalInFourthQuarter	500000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	95000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	365000	usd
CY2024Q1	us-gaap	Description Of Postemployment Benefits DescriptionOfPostemploymentBenefits	These agreements set out the terms under which such persons would receive their past indebtedness except for the employee that resigned, their future remuneration. Each of these agreements provides for all the indebtedness due to the respective persons to become due and payable as soon as the Company shall have either (i) achieved an annual EBITDA of $5 million per annum as indicated by reference to the Annual Report of the Company on Form 10-K or if no such report is filed, in accordance with the audited financial reports presented to the shareholders, or, (ii) achieved a quarterly income figure of $12 million, or, (iii) the Board of Directors of the Company shall declare the Indebtedness due. Until such time as payment is made, all Indebtedness shall incur interest at 8%. The Agreements additionally provide for the respective salaries fixed in the employment agreements to be reduced to at least ¼ of the amount of remuneration set forth in the employment or consulting agreement from March 1, 2024. Remuneration will increase to ½ of the agreed salary either (a) on the date on which the Company shall raise more than $3 million in equity or debt finance, or (b) the date on which the Company shall receive booked revenue
CY2024Q1	CHMX	Indebtedness And Penalty Interest Conversion Description IndebtednessAndPenaltyInterestConversionDescription	(i) the price which is five percent (5%) lower than the average trading price of the five business trading days immediately preceding the date of the election, or (ii), if the Company is in the process of raising finance and has made an offering to the public by reporting the offering to the Securities Exchange Commission (“SEC”), at the price that is five percent (5%) lower than the price recorded in such reported offering provided such offering shall have been active at any time during the previous quarter
CY2024Q1	CHMX	Indebtedness Agreement Description IndebtednessAgreementDescription	The indebtedness of the Company to the signatories shall be accelerated and become immediately due and payable in the event that the Company shall fail: (i) (a) to achieve an annual EBITDA of $5 million per annum, or, (b) to achieve a quarterly income figure of $12 million, or, (c) to declare the Indebtedness on or before February 28, 2027; or (ii) to pay the monthly remuneration agreed in the agreement within 11 days of the month end in which the remuneration was incurred
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	945000	usd
CY2024Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2024Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	35258	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28546834	shares

Files In Submission

Name	View Source	Status
0001493152-24-027787-index-headers.html	Edgar Link	pending
0001493152-24-027787-index.html	Edgar Link	pending
0001493152-24-027787.txt	Edgar Link	pending
0001493152-24-027787-xbrl.zip	Edgar Link	pending
chmx-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
chmx-20240331_cal.xml	Edgar Link	unprocessable
chmx-20240331_def.xml	Edgar Link	unprocessable
chmx-20240331_lab.xml	Edgar Link	unprocessable
chmx-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHMX
NEXT-ChemX Corporation. Stock $chmx

2024 Q3 Form 10-Q Financial Statement

#000149315224027787 Filed on July 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHMX NEXT-ChemX Corporation. Stock $chmx

2024 Q3 Form 10-Q Financial Statement

#000149315224027787 Filed on July 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHMX
NEXT-ChemX Corporation. Stock $chmx